Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00619918 · ClinicalTrials.gov registry record · Phase 2
Nebulized Hypertonic Saline for Bronchiolitis
A Phase 2 study, sponsored by Children's Hospital Los Angeles.
- Completed
- Registry status
- Phase 2
- Development phase
- 447
- Enrollment target
NCT00619918 is a Phase 2 study that has completed, run by Children's Hospital Los Angeles. The registered enrollment target is 447 participants.
The verdict
NCT00619918, a Phase 2 study, has completed, sponsored by Children's Hospital Los Angeles.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 447 participants
- Enrollment target
Study Summary
This study aims to examine the effect of nebulized 3% hypertonic saline in the treatment of viral bronchiolitis. The investigators hypothesize that nebulized 3% saline will decrease rate of hospital admission, decrease clinical severity scores, and decrease length of stay.
Interventions
- DRUG Nebulized 3% saline
- DRUG Nebulized 0.9% saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 447 participants |
| Start Date | 2008-02 |
| Est. Completion | 2011-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00619918
The ClinicalTrials.gov registry entry for NCT00619918 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 447 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Los Angeles, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nebulized 3% saline is the first listed.
NCT00619918 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00619918 about?
NCT00619918 is a clinical study titled "Nebulized Hypertonic Saline for Bronchiolitis". This study aims to examine the effect of nebulized 3% hypertonic saline in the treatment of viral bronchiolitis. The investigators hypothesize that nebulized 3% saline will decrease rate of hospital admission, decrease clinical severity scores, and decrease length of stay.
What is the current status of trial NCT00619918?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 447 participants. The study started on 2008-02. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00619918?
The interventions under investigation include: Nebulized 3% saline (DRUG), Nebulized 0.9% saline (DRUG).
Who is sponsoring clinical trial NCT00619918?
This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.